CDRH names permanent director
Food and Drug Administration Commissioner Dr. Jane Henney this month appointed Dr. David Feigal director of the agency’s Center for Devices and Radiological Health. Feigal replaces former director Dr. Bruce Burlington, who left the FDA in March, and
Food and Drug Administration Commissioner Dr. Jane Henney this month appointed Dr. David Feigal director of the agencys Center for Devices and Radiological Health. Feigal replaces former director Dr. Bruce Burlington, who left the FDA in March, and acting director Elizabeth Jacobson (SCAN 3/3/99). Feigals new position is effective immediately.
Feigal joined the FDA in 1992, and has served as head of the Center for Drug Evaluation and Researchs division of antiviral drug products and as medical deputy director of the FDAs Center for Biologics Evaluation and Research. He was a principal investigator in studies that led the FDA to approve a drug-device combination that was one of the earliest therapies for AIDS.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
